Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator
- PMID: 1409715
- PMCID: PMC50235
- DOI: 10.1073/pnas.89.20.9870
Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator
Abstract
Human immunodeficiency virus type 1 (HIV-1) is the causative agent of the acquired immunodeficiency syndrome (AIDS). Currently, no satisfactory treatment for this viral disease is available. Somatic gene therapy has been proposed as an alternative to conventional therapies. Several antiviral gene therapy approaches including ribozymes, antisense inhibition, and RNA-decoy strategies, as well as dominant-negative mutants of HIV-1 proteins (Gag, Tat, and Rev) have been suggested. To prove the concept of trans-dominant inhibition of HIV-1 replication, we transduced CEM cells with a retroviral vector encoding a dominant-negative rev gene. Amplification of integrase-specific proviral sequences from high molecular weight DNA indicated successful HIV-1 human T-lymphotropic virus type IIIB (HTLV-IIIB) infection of all cells. In contrast to CEM cells and CEM cells expressing the rev wild-type (wt) gene, infection of two CEM-RevM10 clones with HIV-1 did not result in the release of significant levels of p24 Gag antigen as measured by antigen capture assay, indicating a block in HIV-1 replication due to the presence of the trans-dominant Rev protein. Furthermore, the parental CEM cells as well as CEM cells expressing the Rev wt protein were effectively killed in the course of the HIV-1 infection, whereas all CEM cells expressing the RevM10 protein were unaffected in their growth rate.
Similar articles
-
Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.Hum Gene Ther. 1994 Feb;5(2):193-201. doi: 10.1089/hum.1994.5.2-193. Hum Gene Ther. 1994. PMID: 8186299
-
Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.J Virol. 1994 Dec;68(12):8254-64. doi: 10.1128/JVI.68.12.8254-8264.1994. J Virol. 1994. PMID: 7966618 Free PMC article.
-
The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.Hum Gene Ther. 1993 Oct;4(5):625-34. doi: 10.1089/hum.1993.4.5-625. Hum Gene Ther. 1993. PMID: 8280800
-
Inhibition of HIV-1 replication by targeting the Rev protein.Leukemia. 1997 Apr;11 Suppl 3:134-7. Leukemia. 1997. PMID: 9209321 Review.
-
Regulation of expression of human immunodeficiency virus.New Biol. 1990 Jan;2(1):20-31. New Biol. 1990. PMID: 2078551 Review.
Cited by
-
Novel Pol II fusion promoter directs human immunodeficiency virus type 1-inducible coexpression of a short hairpin RNA and protein.J Virol. 2006 Feb;80(4):1863-73. doi: 10.1128/JVI.80.4.1863-1873.2006. J Virol. 2006. PMID: 16439542 Free PMC article.
-
Is gene therapy a good therapeutic approach for HIV-positive patients?Genet Vaccines Ther. 2007 Feb 14;5:5. doi: 10.1186/1479-0556-5-5. Genet Vaccines Ther. 2007. PMID: 17300725 Free PMC article.
-
Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.J Virol. 1996 Jul;70(7):4871-6. doi: 10.1128/JVI.70.7.4871-4876.1996. J Virol. 1996. PMID: 8676525 Free PMC article.
-
Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element.Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14365-70. doi: 10.1073/pnas.0804461105. Epub 2008 Sep 5. Proc Natl Acad Sci U S A. 2008. PMID: 18776047 Free PMC article.
-
Gene therapy. Clinical potential and relationship to drug treatment.Drugs. 1995 Dec;50(6):951-8. doi: 10.2165/00003495-199550060-00003. Drugs. 1995. PMID: 8612473 Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical